435 related articles for article (PubMed ID: 16010034)
1. Stimulatory effects of statins on bone marrow-derived mesenchymal stem cells. Study of a new therapeutic agent for fracture.
Sonobe M; Hattori K; Tomita N; Yoshikawa T; Aoki H; Takakura Y; Suguro T
Biomed Mater Eng; 2005; 15(4):261-7. PubMed ID: 16010034
[TBL] [Abstract][Full Text] [Related]
2. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts.
Heino TJ; Hentunen TA; Väänänen HK
Exp Cell Res; 2004 Apr; 294(2):458-68. PubMed ID: 15023534
[TBL] [Abstract][Full Text] [Related]
3. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
[TBL] [Abstract][Full Text] [Related]
4. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
5. Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells.
Oshina H; Sotome S; Yoshii T; Torigoe I; Sugata Y; Maehara H; Marukawa E; Omura K; Shinomiya K
Bone; 2007 Oct; 41(4):575-83. PubMed ID: 17690025
[TBL] [Abstract][Full Text] [Related]
6. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue.
Hayashi O; Katsube Y; Hirose M; Ohgushi H; Ito H
Calcif Tissue Int; 2008 Mar; 82(3):238-47. PubMed ID: 18305886
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow-derived mesenchymal cells can rescue osteogenic capacity of devitalized autologous bone.
Tohma Y; Ohgushi H; Morishita T; Dohi Y; Tadokoro M; Tanaka Y; Takakura Y
J Tissue Eng Regen Med; 2008 Jan; 2(1):61-8. PubMed ID: 18361480
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells.
Maeda T; Matsunuma A; Kawane T; Horiuchi N
Biochem Biophys Res Commun; 2001 Jan; 280(3):874-7. PubMed ID: 11162604
[TBL] [Abstract][Full Text] [Related]
9. Bone formation-promoting effect of genistein on marrow mesenchymal cell culture.
Okumura N; Yoshikawa T; Iida J; Nonomura A; Takakura Y
Biomed Mater Eng; 2006; 16(1):23-32. PubMed ID: 16410641
[TBL] [Abstract][Full Text] [Related]
10. Culture media conditioned by heat-shocked osteoblasts enhances the osteogenesis of bone marrow-derived mesenchymal stromal cells.
Ye CP; Heng BC; Liu H; Toh WS; Cao T
Cell Biochem Funct; 2007; 25(3):267-76. PubMed ID: 16927416
[TBL] [Abstract][Full Text] [Related]
11. Distinct osteoblastic differentiation potential of murine fetal liver and bone marrow stroma-derived mesenchymal stem cells.
Fromigué O; Hamidouche Z; Chateauvieux S; Charbord P; Marie PJ
J Cell Biochem; 2008 May; 104(2):620-8. PubMed ID: 18080317
[TBL] [Abstract][Full Text] [Related]
12. The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passages.
Ishikawa H; Kitoh H; Sugiura F; Ishiguro N
Acta Orthop; 2007 Apr; 78(2):285-92. PubMed ID: 17464620
[TBL] [Abstract][Full Text] [Related]
13. Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell.
Sila-Asna M; Bunyaratvej A; Maeda S; Kitaguchi H; Bunyaratavej N
Kobe J Med Sci; 2007; 53(1-2):25-35. PubMed ID: 17579299
[TBL] [Abstract][Full Text] [Related]
14. The role of muscle-derived stem cells in bone tissue engineering.
Sun JS; Wu SY; Lin FH
Biomaterials; 2005 Jun; 26(18):3953-60. PubMed ID: 15626442
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcal enterotoxin C injection in combination with ascorbic acid promotes the differentiation of bone marrow-derived mesenchymal stem cells into osteoblasts in vitro.
Wan XC; Liu CP; Li M; Hong D; Li DM; Chen HX; Li JC
Biochem Biophys Res Commun; 2008 Sep; 373(4):488-92. PubMed ID: 18572015
[TBL] [Abstract][Full Text] [Related]
16. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.
Chen ZX; Chang M; Peng YL; Zhao L; Zhan YR; Wang LJ; Wang R
Regul Pept; 2007 Jul; 142(1-2):16-23. PubMed ID: 17331598
[TBL] [Abstract][Full Text] [Related]
17. In vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on beta-tricalcium phosphate.
Matsushima A; Kotobuki N; Tadokoro M; Kawate K; Yajima H; Takakura Y; Ohgushi H
Artif Organs; 2009 Jun; 33(6):474-81. PubMed ID: 19473144
[TBL] [Abstract][Full Text] [Related]
18. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells.
Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y
J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871
[TBL] [Abstract][Full Text] [Related]
19. Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential.
Castano-Izquierdo H; Alvarez-Barreto J; van den Dolder J; Jansen JA; Mikos AG; Sikavitsas VI
J Biomed Mater Res A; 2007 Jul; 82(1):129-38. PubMed ID: 17269144
[TBL] [Abstract][Full Text] [Related]
20. Proliferation and differentiation of mesenchymal stem cells using self-assembled peptide amphiphile nanofibers.
Hosseinkhani H; Hosseinkhani M; Kobayashi H
Biomed Mater; 2006 Mar; 1(1):8-15. PubMed ID: 18458380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]